You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

milademetan

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumor, CDKN2A, NSCLC Trial (Milademetan, Atezolizumab)

Withdrawn
  • Advanced Solid Tumor
  • +9 more
  • (no location specified)
Oct 16, 2023

Advanced or Metastatic Breast Cancer Trial in Paris (Milademetan, Patient Reported Outcomes (PROs) and Health-Related Quality of

Not yet recruiting
  • Advanced or Metastatic Breast Cancer
  • Milademetan
  • Patient Reported Outcomes (PROs) and Health-Related Quality of Life (HRQOL)
  • Paris, France
    Institut Curie
Jun 27, 2023

Cardiac Repolarization Trial in Melbourne (Placebo, Moxifloxacin (positive control), Milademetan)

Not yet recruiting
  • Cardiac Repolarization
  • Placebo
  • +2 more
  • Melbourne, Victoria, Australia
    Nucleus Network Melbourne
Mar 6, 2023

Acute Myeloid Leukemia Trial in United States (Quizartinib, Milademetan)

Terminated
Has Results
  • Acute Myeloid Leukemia
  • Los Angeles, California
  • +7 more
Mar 14, 2022

Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in United States (Milademetan, AZA)

Terminated
Has Results
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • Duarte, California
  • +4 more
Sep 14, 2021

Advanced Solid Tumor, Lymphoma Trial in United States (Milademetan)

Completed
  • Advanced Solid Tumor
  • Lymphoma
  • Milademetan
  • Detroit, Michigan
  • +4 more
Dec 4, 2020

Acute Myeloid Leukemia Trial in Japan (Milademetan)

Completed
  • Acute Myeloid Leukemia
  • Milademetan
  • Chiba, Japan
  • +7 more
Oct 28, 2019

Pharmacokinetics Trial in Dallas (Milademetan, Itraconazole, Posaconazole)

Completed
  • Pharmacokinetics
  • Milademetan
  • +2 more
  • Dallas, Texas
    Covance Clinical Research Unit, Inc.
Feb 8, 2019